Evidence map›Paper›PMID 32199103›Full record

ArticleNeuron2020

Alzheimer's Risk Factors Age, APOE Genotype, and Sex Drive Distinct Molecular Pathways.

Na Zhao, Yingxue Ren, Yu Yamazaki, Wenhui Qiao, Fuyao Li, Lindsey M Felton, Siamak Mahmoudiandehkordi, Alexandra Kueider-Paisley, Berkiye Sonoustoun, Matthias Arnold and 22 more

Open access · bronzeAbstract read
In one paragraph

Article in Neuron, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 145 papers.

0numbers the graph read from it
0cells of the map it votes in
145citing papers in PubMed
17.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

145 citing papers in PubMed, 251 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Roles of TREM2 in Alzheimer's disease.Translational neurodegeneration · 2025
    Review
  17. Article
  18. Article
  19. Emerging Role of Oligodendrocytes Malfunction in the Progression of Alzheimer's Disease.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2025
    Review
  20. Article

85 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 4 institutions in 2 countries.

Na ZhaoDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA. Electronic address: zhao.na@mayo.edu.
Yingxue RenDepartment of Health Sciences Research, Mayo Clinic, Jacksonville, FL 32224, USA.
Yu YamazakiDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA.
Wenhui QiaoDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA.
Fuyao LiDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA.
Lindsey M FeltonDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA.
Siamak MahmoudiandehkordiDepartment of Psychiatry and Behavioral Sciences, Department of Medicine and the Duke Institute for Brain Sciences, Duke University, Durham, NC 27708, USA.
Alexandra Kueider-PaisleyDepartment of Psychiatry and Behavioral Sciences, Department of Medicine and the Duke Institute for Brain Sciences, Duke University, Durham, NC 27708, USA.
Berkiye SonoustounDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA.
Matthias ArnoldDepartment of Psychiatry and Behavioral Sciences, Department of Medicine and the Duke Institute for Brain Sciences, Duke University, Durham, NC 27708, USA; Institute of Bioinformatics and Systems Biology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Bavaria 85764, Germany.
Francis ShueNeuroscience Graduate Program, Mayo Clinic, Jacksonville, FL 32224, USA.
Jiaying ZhengNeuroscience Graduate Program, Mayo Clinic, Jacksonville, FL 32224, USA.
Olivia N AttrebiDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA.
Yuka A MartensDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA.
Zonghua LiDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA.
Ligia BasteaDepartment of Cancer Biology, Mayo Clinic, Jacksonville, FL 32224, USA.
Axel D MenesesDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA.
Kai ChenDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA.
J Will ThompsonDuke Proteomics and Metabolomics Shared Resource, Center for Genomic and Computational Biology, Duke University, Durham, NC 27708, USA; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC 27701, USA.
Lisa St John-WilliamsDuke Proteomics and Metabolomics Shared Resource, Center for Genomic and Computational Biology, Duke University, Durham, NC 27708, USA.
Masaya TachibanaDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA.
Tomonori AikawaDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA.
Hiroshi OueDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA.
Lucy JobDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA.
Akari YamazakiDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA.
Chia-Chen LiuDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA.
Peter StorzDepartment of Cancer Biology, Mayo Clinic, Jacksonville, FL 32224, USA.
Yan W AsmannDepartment of Health Sciences Research, Mayo Clinic, Jacksonville, FL 32224, USA.
Nilüfer Ertekin-TanerDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA; Department of Neurology, Mayo Clinic, Jacksonville, FL 32224, USA.
Takahisa KanekiyoDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA.
Rima Kaddurah-DaoukDepartment of Psychiatry and Behavioral Sciences, Department of Medicine and the Duke Institute for Brain Sciences, Duke University, Durham, NC 27708, USA.
Guojun BuDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA; Neuroscience Graduate Program, Mayo Clinic, Jacksonville, FL 32224, USA. Electronic address: bu.guojun@mayo.edu.
Mayo Clinic in Florida · USDuke University · USHelmholtz Zentrum München · DEJacksonville College · US

Funding

Vascular Structure and Function in Cognitive AgingP01AG003949 · NIA · YESHIVA UNIVERSITY · PI Jelena Pavlovic · 1985 to 2026
$73.9M
SUPPLEMENT TO ALZHEIMERS DISEASE PATIENT REGISTRYU01AG006786 · NIA · MAYO CLINIC ROCHESTER · PI GRAFF-RADFORD, JONATHAN, JACK, CLIFFORD R. · 1986 to 2023
$49.6M
SUPPLEMENT TO RUSH ALZHEIMERS DISEASE CENTER COREP30AG010161 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 1991 to 2020
$49.1M
EPIDEMIOLOGY OF NEURAL RESERVE AND NEUROBIOLOGY IN AGINGR01AG017917 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 2001 to 2023
$43.3M
THE PGRN/TDP-43 AXIS IN ALZHEIMER?S DISEASE AND NEURODEGENERATIONP50AG016574 · NIA · MAYO CLINIC ROCHESTER · PI BU, GUOJUN · 1999 to 2018
$36.9M
Research Education ComponentP30AG019610 · NIA · SUN HEALTH RESEARCH INSTITUTE · PI GONZALEZ HERNANDEZ, GRACIELA · 2001 to 2020
$32.5M
Integrating the exposome and methylome to inform brain molecular changes in ADRD across established diverse cohorts.U01AG046139 · NIA · UNIVERSITY OF FLORIDA · PI ERTEKIN-TANER, NILUFER, PETERS, METTE · 2013 to 2022
$24.6M
RISK FACTORS, PATHOLOGY, AND CLINICAL EXPRESSIONS OF ADR01AG015819 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 1998 to 2024
$21.4M
Viral Vectors CoreP01NS074969 · NINDS · WASHINGTON UNIVERSITY · PI SNIDER, BARBARA JOY · 2012 to 2021
$13.0M
TRANSGENIC MODELING OF TAUOPATHYP01AG017216 · NIA · MAYO CLINIC JACKSONVILLE · PI DICKSON, DENNIS WILLIAM · 1999 to 2011
$12.0M
Metabolomic Signatures for Disease Sub-classification and Target Prioritization in AMP-ADU01AG061359 · NIA · DUKE UNIVERSITY · PI KADDURAH-DAOUK, RIMA F, KASTENMULLER, GABI · 2018 to 2022
$10.0M
Integrative translational discovery of vascular risk factors in aging and dementiaRF1AG051504 · NIA · MAYO CLINIC JACKSONVILLE · PI BU, GUOJUN, ERTEKIN-TANER, NILUFER · 2015 to 2019
$9.8M
NCI NIH HHS R01 CA200572NIA NIH HHS F31 AG051356NIA NIH HHS P01 AG003949NIA NIH HHS P01 AG017216NIA NIH HHS P30 AG010161NIA NIH HHS P30 AG019610NIA NIH HHS P50 AG016574NIA NIH HHS P50 AG025711NIA NIH HHS R01 AG015819NIA NIH HHS R01 AG017917NIA NIH HHS R01 AG018023NIA NIH HHS R01 AG027924NIA NIH HHS R01 AG032990NIA NIH HHS R01 AG035355NIA NIH HHS R01 AG046171NIA NIH HHS R01 AG061796NIA NIH HHS R01 AG066395NIA NIH HHS R21 AG052423NIA NIH HHS R37 AG027924NIA NIH HHS RF1 AG046205NIA NIH HHS RF1 AG051504NIA NIH HHS RF1 AG051550NIA NIH HHS RF1 AG056130NIA NIH HHS RF1 AG057181NIA NIH HHS RF1 AG062110NIA NIH HHS U01 AG006786NIA NIH HHS U01 AG046139NIA NIH HHS U01 AG061359NINDS NIH HHS P01 NS074969NINDS NIH HHS R01 NS080820NINDS NIH HHS U24 NS072026
6 · The paper itself

Abstract

Evidence suggests interplay among the three major risk factors for Alzheimer's disease (AD): age, APOE genotype, and sex. Here, we present comprehensive datasets and analyses of brain transcriptomes and blood metabolomes from human apoE2-, apoE3-, and apoE4-targeted replacement mice across young, middle, and old ages with both sexes. We found that age had the greatest impact on brain transcriptomes highlighted by an immune module led by Trem2 and Tyrobp, whereas APOE4 was associated with upregulation of multiple Serpina3 genes. Importantly, these networks and gene expression changes were mostly conserved in human brains. Finally, we observed a significant interaction between age, APOE genotype, and sex on unfolded protein response pathway. In the periphery, APOE2 drove distinct blood metabolome profile highlighted by the upregulation of lipid metabolites. Our work identifies unique and interactive molecular pathways underlying AD risk factors providing valuable resources for discovery and validation research in model systems and humans.

Indexed as

Adaptor Proteins, Signal TransducingAge FactorsAgingAlzheimer DiseaseAnimalsApolipoprotein E2Apolipoprotein E3Apolipoprotein E4Apolipoproteins EBrainFemaleGene ExpressionGene Expression ProfilingGene Regulatory NetworksGenotypeHumansAdaptor Proteins, Signal TransducingApoE protein, humanApolipoprotein E2Apolipoprotein E3Apolipoprotein E4Apolipoproteins EMembrane GlycoproteinsMembrane ProteinsReceptors, ImmunologicSerpinsTREM2 protein, humanTYROBP protein, humanageAlzheimer’s diseaseAPOEextracellular vesiclesinflammationlipid metabolismmetabolomicsSerpina3sextranscriptomics

Identifiers

PMID32199103
PMCPMC7388065
OpenAlexW3011658331

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.